Daiwa Securities Group’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-265
| Closed | -$14K | – | 1440 |
|
|
2022
Q3 | $14K | Hold |
265
| – | – | ﹤0.01% | 1114 |
|
|
2022
Q2 | $7K | Buy |
265
+61
| +30% | +$1.34K | ﹤0.01% | 1154 |
|
|
2022
Q1 | $5K | Hold |
204
| – | – | ﹤0.01% | 1183 |
|
|
2021
Q4 | $7K | Sell |
204
-35
| -15% | -$1.23K | ﹤0.01% | 1176 |
|
|
2021
Q3 | $4K | Buy |
239
+102
| +74% | +$1.59K | ﹤0.01% | 1204 |
|
|
2021
Q2 | $2K | Hold |
137
| – | – | ﹤0.01% | 1166 |
|
|
2021
Q1 | $7K | Buy |
137
+7
| +5% | +$421 | ﹤0.01% | 1064 |
|
|
2020
Q4 | $8K | Sell |
130
-259
| -67% | -$14.8K | ﹤0.01% | 1031 |
|
|
2020
Q3 | $21K | Buy |
389
+60
| +18% | +$3.23K | ﹤0.01% | 987 |
|
|
2020
Q2 | $13K | Hold |
329
| – | – | ﹤0.01% | 1054 |
|
|
2020
Q1 | $13K | Hold |
329
| – | – | ﹤0.01% | 1043 |
|
|
2019
Q4 | $13K | Sell |
329
-36
| -10% | -$632 | ﹤0.01% | 1040 |
|
|
2019
Q3 | $2K | Hold |
365
| – | – | ﹤0.01% | 1142 |
|
|
2019
Q2 | $3K | Buy |
365
+96
| +36% | +$1.11K | ﹤0.01% | 1137 |
|
|
2019
Q1 | $4K | Hold |
269
| – | – | ﹤0.01% | 1101 |
|
|
2018
Q4 | $3K | Hold |
269
| – | – | ﹤0.01% | 1099 |
|
|
2018
Q3 | $3K | Hold |
269
| – | – | ﹤0.01% | 1116 |
|
|
2018
Q2 | $4K | Hold |
269
| – | – | ﹤0.01% | 1112 |
|
|
2018
Q1 | $4K | Buy |
+269
| New | +$2.77K | ﹤0.01% | 1096 |
|
Other funds holding CCXI
Daiwa Securities Group's CCXI Position: Q4 2022 in Review
Daiwa Securities Group sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 265 shares — an estimated $14K sold.
Daiwa Securities Group first reported a position in CCXI in Q1 2018 and held it in 19 quarters. The position peaked at $21K in Q3 2020. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.
- Daiwa Securities Group reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
- Daiwa Securities Group sold 265 ChemoCentryx, Inc. shares in Q4 2022, an estimated $14K.
- Daiwa Securities Group first reported a position in ChemoCentryx, Inc. in Q1 2018 and held it in 19 quarters.
- Daiwa Securities Group's ChemoCentryx, Inc. position peaked at $21K in Q3 2020.
- 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.
Based on Daiwa Securities Group's 13F filing for Q4 2022, filed 6 Feb 2023.